Fiduciary Alliance LLC Acquires 1,805 Shares of Humana Inc. $HUM

Fiduciary Alliance LLC raised its holdings in Humana Inc. (NYSE:HUM) by 34.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,976 shares of the insurance provider’s stock after buying an additional 1,805 shares during the period. Fiduciary Alliance LLC’s holdings in Humana were worth $1,705,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in HUM. Vanguard Group Inc. lifted its stake in shares of Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after buying an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Humana by 3,257.5% in the first quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock valued at $307,624,000 after purchasing an additional 1,127,973 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Humana by 40,881.1% in the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider’s stock valued at $2,066,790,000 after purchasing an additional 779,193 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Humana in the first quarter valued at about $171,220,000. Finally, Dodge & Cox raised its holdings in shares of Humana by 5.5% in the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after purchasing an additional 557,175 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on HUM shares. Barclays increased their target price on shares of Humana from $275.00 to $315.00 and gave the company an “equal weight” rating in a report on Friday, September 5th. Morgan Stanley lowered their target price on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Bank of America increased their target price on shares of Humana from $285.00 to $312.00 and gave the company a “neutral” rating in a report on Tuesday, September 2nd. Truist Financial lowered their target price on shares of Humana from $280.00 to $260.00 and set a “hold” rating for the company in a report on Wednesday, July 16th. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Seven analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $289.24.

Humana Price Performance

HUM stock opened at $272.04 on Wednesday. The firm has a 50 day moving average of $266.79 and a 200-day moving average of $257.30. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $324.38. The firm has a market capitalization of $32.72 billion, a P/E ratio of 20.88, a price-to-earnings-growth ratio of 1.62 and a beta of 0.44.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter in the previous year, the firm earned $6.96 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s payout ratio is presently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.